Mylan

FDA extends EpiPen expiration date to ease shortages
FDA extends EpiPen expiration date to ease shortages
Biopharma Dive
Mylan
drug shortages
FDA
EpiPens
Flag link:
Mylan's EpiPen supply woes drag on
Mylan's EpiPen supply woes drag on
Biopharma Dive
Mylan
Pfizer
EpiPens
drug shortages
Flag link:
FDA Approves New Generic Version Of The EpiPen For Allergic Reactions
FDA Approves New Generic Version Of The EpiPen For Allergic Reactions
NPR
EpiPens
generics
Teva Pharmaceutical
Mylan
allergic reaction
Flag link:
Mylan Launches First Adcirca Generic, Stock Moves Up
Mylan Launches First Adcirca Generic, Stock Moves Up
Market Realist
Mylan
tadalafil
generics
PAH
Adcirca
United Therapeutics
Flag link:
Mylan signs U.S. license deal on Humira with AbbVie
Mylan signs U.S. license deal on Humira with AbbVie
Yahoo/Reuters
AbbVie
Mylan
biosimilars
Humira
Flag link:
Mylan decimates the list price of its Copaxone copy. But why?
Mylan decimates the list price of its Copaxone copy. But why?
Fierce Pharma
Mylan
drug pricing
Copaxone
Flag link:
Mylan launches generic drug-delivery patch for dementia patients
Mylan launches generic drug-delivery patch for dementia patients
Drug Delivery Business News
Mylan
rivastigmine
generics
Novartis
Exelon
dementia
Alzheimer's disease
Parkinson's Disease
Flag link:
Novartis steps in to compete with Mylan’s Epipen
Novartis steps in to compete with Mylan’s Epipen
Drug Delivery Business News
Adamis Pharmaceuticals
Novartis
Sandoz
Symjepi
Mylan
EpiPens
Flag link:
GSK wins yet another reprieve for blockbuster Advair franchise as Mylan is hit (again) with a CRL
GSK wins yet another reprieve for blockbuster Advair franchise as Mylan is hit (again) with a CRL
Endpoints
Mylan
FDA
Advair
GSK
complete response letter
Flag link:
DoJ investigates Mylan on trade compliance for certain products
DoJ investigates Mylan on trade compliance for certain products
Reuters
DOJ
Mylan
Trade Agreements Act
Flag link:
Coherus BioSciences Re-Submits BLA for Neulasta (Pegfilgrastim) Biosimilar Candidate
Coherus BioSciences Re-Submits BLA for Neulasta (Pegfilgrastim) Biosimilar Candidate
CP Wire
Coherus Biosciences
Neulasta
CHS-1701
Mylan
Biocon
Flag link:
Coherus BioSciences Re-Submits BLA for Neulasta (Pegfilgrastim) Biosimilar Candidate
Coherus Biosciences
Neulasta
CHS-1701
Mylan
Biocon
Flag link:
Generic-Drug Companies to Face First Charges in U.S. Probe
Generic-Drug Companies to Face First Charges in U.S. Probe
Bloomberg
generics
Mylan
Perrigo
Teva Pharmaceutical
price fixing
Flag link:
Mylan cuts workforce at West Virginia plant by 15%
Mylan cuts workforce at West Virginia plant by 15%
Biopharma Dive
Mylan
layoffs
drug manufacturing
Flag link:
Fujifilm Kyowa Kirin Biologics Partners with Mylan to Commercialize Biosimilar to Humira in Europe
Fujifilm Kyowa Kirin Biologics Partners with Mylan to Commercialize Biosimilar to Humira in Europe
CP Wire
Humira
Mylan
Fujifilm
AbbVie
biosimilars
FKB327
Flag link:
Fujifilm Kyowa Kirin Biologics Partners with Mylan to Commercialize Biosimilar to Humira in Europe
Humira
Mylan
Fujifilm
Flag link:
Mylan, Theravance’s inhaled COPD therapy proves safe in late-stage trial
Mylan, Theravance’s inhaled COPD therapy proves safe in late-stage trial
Drug Delivery Business News
Mylan
Theravance
COPD
clinical trials
revefenacin
Flag link:
Mylan's Copaxone copy could face another hold-up with FDA info request
Mylan's Copaxone copy could face another hold-up with FDA info request
Fierce Pharma
Mylan
Copaxone
FDA
generics
Teva Pharmaceutical
MS
multiple sclerosis
Flag link:
Mylan EpiPen recall goes global but company says it has plenty of replacements
Mylan EpiPen recall goes global but company says it has plenty of replacements
Fierce Pharma
Mylan
EpiPens
recalls
Flag link:
2016 went out like a lamb in the biopharma M&A world. Will it roar back in 2017? Plus, top 10 deals
2016 went out like a lamb in the biopharma M&A world. Will it roar back in 2017? Plus, top 10 deals
Endpoints
M&A
Shire
Baxalta
Pfizer
Medivation
Mylan
Meda
AbbVie
Stemcentrx
Anacor
Flag link:

Pages